A Furan-Containing Insurmountable Antagonist and Inverse Agonist of the Adenosine A2A Receptor for Parkinson’s Disease

KW-6356

oral A_2A receptor antagonist/inverse agonist Ph. II for Parkinson’s Disease 2^nd gen. A_2A receptor antagonist ASPET, March 9, 2023 Kyowa Kirin Co., Ltd., Shizuoka, JP

Drug Hunter Team

KW-6356, oral A2A receptor antagonist/inverse agonist, Ph. II for Parkinson’s Disease, 2nd gen. A2A receptor antagonist, ASPET, March 9, 2023, KYOWA KIRIN CO., LTD., SHIZUOKA, JP

A Furan-Containing Insurmountable Antagonist and Inverse Agonist of the Adenosine A2A Receptor for Parkinson’s Disease

KW-6356

Other molecules you may be interested in